What is Climb Bio, Inc.'s earnings yield?

Climb Bio, Inc. (CLYM) reported earnings yield of -16.1% in Q1 2026.

How has Climb Bio, Inc.'s earnings yield changed year-over-year?

Climb Bio, Inc.'s earnings yield increased by 85.7% year-over-year, from -113% to -16.1%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Climb Bio, Inc. CLYM Earnings yield

Earnings yield at other companies

Bristol-Myers SquibbBMY

5.9%+1.6pp

AmgenAMGN

4.1%+0.6pp

Vera TherapeuticsVERA

-12.9%+1.8pp

Kyverna Therapeutics, Inc.KYTX

-30%-13.6pp

Cullinan Therapeutics, Inc.CGEM

-25.7%-6.8pp

Jade Biosciences, Inc. Common StockJBIO

-18.7%—

Other financials

Income statement

See full

Operating income-$15.2M+33.9%

Net income-$13.7M+34.0%

EPS (diluted)-$0.20+35.5%

Balance sheet

See full

Cash & equivalents$8.4M-71.2%

Total debt$479.0K+1.1%

Total equity$148.1M-23.4%

Total assets$152.4M-24.1%

Cash flow

See full

Operating cash flow-$14.4M+6.8%

CapEx$109.0K—

Free cash flow-$15.6M-183%

Valuation

See full

Market cap$724.95M+787%

Enterprise value$717.07M+1,247%

Returns & leverage

See full

Return on equity-30.9%-10.3pp

Debt / equity0×0.0×

Current ratio27.9×+13.6×

Where this comes from

Calculated from Climb Bio, Inc.’s reported figures.

net income/market cap=-16.1%

Based on trailing twelve months.

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Climb Bio, Inc.'s earnings yield?: Climb Bio, Inc. (CLYM) reported earnings yield of -16.1% in Q1 2026.
How has Climb Bio, Inc.'s earnings yield changed year-over-year?: Climb Bio, Inc.'s earnings yield increased by 85.7% year-over-year, from -113% to -16.1%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.